The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the occurrence of tumors of the parathyroids, pancreas, and anterior pituitary. The MEN1 gene, which was identified in 1997, consists of 10 exons that encode a 610-amino acid protein referred to as menin. Menin is predominantly a nuclear protein that has roles in transcriptional regulation, genome stability, cell division, and proliferation. Germline mutations usually result in MEN1 or occasionally in an allelic variant referred to as familial isolated hyperparathyroidism (FIHP). MEN1 tumors frequently have loss of heterozygosity (LOH) of the MEN1 locus, which is consistent with a tumor suppressor role of MEN1. Furthermore, somatic abnormalities of MEN1 have been reported in MEN1 and non-MEN1 endocrine tumors. The clinical aspects and molecular genetics of MEN1 are reviewed together with the reported 1,336 mutations. The majority (>70%) of these mutations are predicted to lead to truncated forms of menin. The mutations are scattered throughout the>9-kb genomic sequence of the MEN1 gene. Four, which consist of c.249_252delGTCT (deletion at codons 83-84), c.1546_1547insC (insertion at codon 516), c.1378C>T (Arg460Ter), and c.628_631delACAG (deletion at codons 210-211) have been reported to occur frequently in 4.5%, 2.7%, 2.6%, and 2.5% of families, respectively. However, a comparison of the clinical features in patients and their families with the same mutations reveals an absence of phenotype-genotype correlations. The majority of MEN1 mutations are likely to disrupt the interactions of menin with other proteins and thereby alter critical events in cell cycle regulation and proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Two G Protein Oncogenes in Human Endocrine Tumors
Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.-Y., Clark, O. H., Kawasaki, E., Bourne, H. R., et al. (1990) · Science · doi:10.1126/science.2116665 · Cited by 1,037
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
Nomenclature for the description of human sequence variations
den Dunnen, J., & Antonarakis, S. (2001) · Human Genetics · doi:10.1007/s004390100505 · Cited by 896
Genetic aspects of adenomatosis of endocrine glands
Wermer, P. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90353-8 · Cited by 860
Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., & Cleary, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5639-5649.2004 · Cited by 662
Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus
Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00081-4 · Cited by 645
Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription
Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80967-8 · Cited by 627
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Lemmens, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1177 · Cited by 611
Genomic variants in exons and introns: identifying the splicing spoilers
Pagani, F., & Baralle, F. E. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1327 · Cited by 606
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596
Splicing in action: assessing disease causing sequence changes
Baralle, D., & Baralle, M. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.029538 · Cited by 508
Agarwal, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1169 · Cited by 477
Characterization of junD: a new member of the jun proto-oncogene family.
Hirai, S. I., Ryseck, R. P., Mechta, F., Bravo, R., & Yaniv, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03525.x · Cited by 474
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1118 · Cited by 472
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
Self-citationMenin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
Milne, T. A., Hughes, C. M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R. W., Krankel, C., LiVolsi, V. A., Gibbs, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408836102 · Cited by 469
jun-D: a third member of the jun gene family.
Ryder, K., Lanahan, A., Perez-Albuerne, E., & Nathans, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1500 · Cited by 451
Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1
Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Edwards, C. R., Monson, J. P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301729 · Cited by 444
Self-citationMenin, the product of the MEN1 gene, is a nuclear protein
Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., & Chandrasekharappa, S. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1630 · Cited by 434
Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease
Khajavi, M., Inoue, K., & Lupski, J. R. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201649 · Cited by 417
Somatic mutation of the MEN1 gene in parathyroid tumours
Heppner, C., Kester, M. B., Agarwal, S. K., Debelenko, L. V., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Olufemi, S.-E., Skarulis, M. C., Doppman, J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-375 · Cited by 415
Karnik, S. K., Hughes, C. M., Gu, X., Rozenblatt-Rosen, O., McLean, G. W., Xiong, Y., Meyerson, M., & Kim, S. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503484102 · Cited by 403
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Lin, S.-Y., & Elledge, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00430-6 · Cited by 363
Multiple endocrine neoplasia type 1.
Pannett, A. A., & Thakker, R. V. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060449 · Cited by 345
Self-citationThakker, R. V., Bouloux, P., Wooding, C., Chotai, K., Broad, P. M., Spurr, N. K., Besser, G. M., & O'Riordan, J. L. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210403 · Cited by 334
Self-citationClonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1
Friedman, E., Sakaguchi, K., Bale, A. E., Falchetti, A., Streeten, E., Zimering, M. B., Weinstein, L. S., McBride, W. O., Nakamura, Y., Brandi, M.-L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210402 · Cited by 334
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
Pfarr, C. M., Mechta, F., Spyrou, G., Lallemand, D., Carillo, S., & Yaniv, M. (1994) · Cell · doi:10.1016/0092-8674(94)90513-4 · Cited by 311
Kaji, H., Canaff, L., Lebrun, J.-J., Goltzman, D., & Hendy, G. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061358098 · Cited by 300
Byström, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., & Nordenskjöld, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1968 · Cited by 295
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W. S., Agarwal, S. K., Debelenko, L., Kester, M. B., et al. (1997) · PubMed · Cited by 294
Heppner, C., Bilimoria, K. Y., Agarwal, S. K., Kester, M., Whitty, L. J., Guru, S. C., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204529 · Cited by 257
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
Debelenko, L. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2285 · Cited by 257
Bertolino, P., Tong, W.-M., Galendo, D., Wang, Z.-Q., & Zhang, C.-X. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0154 · Cited by 255
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Kuzmiak, H. A., & Maquat, L. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.005 · Cited by 253
Lethality of Multiple Endocrine Neoplasia Type I
Doherty, G. M., Olson, J. A., Frisella, M. M., Lairmore, T. C., Wells, S. A., & Norton, J. A. (1998) · World Journal of Surgery · doi:10.1007/s002689900438 · Cited by 252
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., Weil, R. J., Oldfield, E. H., Park, W. S., Pack, S., Huang, S. C., Agarwal, S. K., Guru, S. C., et al. (1997) · PubMed · Cited by 246
Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 Tumorigenesis
Scacheri, P. C., Davis, S., Odom, D. T., Crawford, G. E., Perkins, S., Halawi, M. J., Agarwal, S. K., Marx, S. J., Spiegel, A. M., Meltzer, P. S., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020051 · Cited by 221
Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation
Dreijerink, K. M. A., Mulder, K. W., Winkler, G. S., Höppener, J. W. M., Lips, C. J. M., & Timmers, H. T. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4461 · Cited by 215
Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., Wautot, V., Salandre, J., Buisson, N., Waterlot, C., Bauters, C., Porchet, N., Aubert, J.-P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301953 · Cited by 211
Sowa, H., Kaji, H., Hendy, G. N., Canaff, L., Komori, T., Sugimoto, T., & Chihara, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401312200 · Cited by 173
Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century
Thakker, R. V. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2617 · Cited by 169
Self-citationKim, H., Lee, J., Cho, E., Liu, J. O., & Youn, H. (2003) · PubMed · Cited by 165
Teh, B. T., Kytölä, S., Farnebo, F., Bergman, L., Wong, F. K., Weber, G., Hayward, N., Larsson, C., Skogseid, B., Beckers, A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5059 · Cited by 160
Menin associates with FANCD2, a protein involved in repair of DNA damage.
Jin, S., Mao, H., Schnepp, R. W., Sykes, S. M., Silva, A. C., D’Andrea, A. D., & Hua, X. (2003) · PubMed · Cited by 157
Cause of Death in Multiple Endocrine Neoplasia Type 1
Wilkinson, S. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420180085016 · Cited by 151
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.
Thakker, R. V., Pook, M. A., Wooding, C., Boscaro, M., Scanarini, M., & Clayton, R. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116524 · Cited by 148
Self-citationMenin and its interacting proteins: elucidation of menin function
Balogh, K., Rácz, K., Patócs, A., & Hunyady, L. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.09.004 · Cited by 141
Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia Type I
Benson, L., Ljunghall, S., Åkerström, G., & Öberg, K. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90008-8 · Cited by 141
Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang, E. H., Ebrahimi, S. A., Wu, A. Y., Kashefi, C., Passaro, E., & Sawicki, M. P. (1998) · PubMed · Cited by 138
Teh, B. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2621 · Cited by 138
Sukhodolets, K. E., Hickman, A. B., Agarwal, S. K., Sukhodolets, M. V., Obungu, V. H., Novotny, E. A., Crabtree, J. S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.493-509.2003 · Cited by 132
Menin Molecular Interactions: Insights into Normal Functions and Tumorigenesis
Agarwal, S. K., Kennedy, P. A., Scacheri, P. C., Novotny, E. A., Hickman, A. B., Cerrato, A., Rice, T., Moore, J. B., Rao, S. G., Ji, Y., et al. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870139 · Cited by 130
Yaguchi, H., Ohkura, N., Takahashi, M., Nagamura, Y., Kitabayashi, I., & Tsukada, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6569-6580.2004 · Cited by 117
Burgess, J. R., Shepherd, J. J., Parameswaran, V., Hoffman, L., & Greenaway, T. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675591 · Cited by 116
Expression of the MEN‐1 gene in a large kindred with multiple endocrine neoplasia type 1
Burgess, Greenaway, & Shepherd (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00275.x · Cited by 113
La, P., Desmond, A., Hou, Z., Silva, A. C., Schnepp, R. W., & Hua, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209400 · Cited by 112
Scacheri, P. C., Crabtree, J. S., Novotny, E. A., Garrett-Beal, L. J., Chen, A., Edgemon, K., Marx, S. J., Spiegel, A. M., Chandrasekharappa, S. C., & Collins, F. S. (2001) · genesis · doi:10.1002/gene.1072 · Cited by 111
Stable overexpression of MEN1 suppresses tumorigenicity of RAS
Kim, Y. S., Burns, A. L., Goldsmith, P. K., Heppner, C., Park, S. Y., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., & Marx, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203005 · Cited by 110
Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1
Loffler, K. A., Biondi, C., Gartside, M. G., Waring, P., Stark, M. S., Serewko-Auret, M. M., Muller, H. K., Hayward, N. K., & Kay, G. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.22288 · Cited by 107
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation
Gallo, A., Cuozzo, C., Esposito, I., Maggiolini, M., Bonofiglio, D., Vivacqua, A., Garramone, M., Weiß, C., Bohmann, D., & Musti, A. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205822 · Cited by 101
Somatic Mutations in MEN Type 1 Tumors, Consistent with the Knudson “Two-Hit” Hypothesis
Pannett, A. A. J., & Thakker, R. V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7844 · Cited by 100
Self-citationSowa, H., Kaji, H., Canaff, L., Hendy, G. N., Tsukamoto, T., Yamaguchi, T., Miyazono, K., Sugimoto, T., & Chihara, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302044200 · Cited by 100
MEN1 Gene mutation analysis of sporadic adrenocortical lesions
G�rtz, B., Roth, J., Speel, E. M., Kr�henmann, A., de Krijger, R. R., Matías‐Guiu, X., Muletta-Feurer, S., R�tmann, K., Saremaslani, P., Heitz, P. U., et al. (1999) · International Journal of Cancer · Cited by 95
Lopez-Egido, J. R. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5575 · Cited by 95
Tanaka, C., Kimura, T., Yang, P., Moritani, M., Yamaoka, T., Yamada, S., Sano, T., Yoshimoto, K., & Itakura, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4888 · Cited by 95
Multiple endocrine neoplasia syndromes
Lips, C. J. M., Vasen, H. F. A., & Lamers, C. B. H. W. (1984) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(84)80017-7 · Cited by 95
Direct Binding of DNA by Tumor Suppressor Menin
La, P., Silva, A. C., Hou, Z., Wang, H., Schnepp, R. W., Yan, N., Shi, Y., & Hua, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409358200 · Cited by 91
Busygina, V., Kottemann, M. C., Scott, K. L., Plon, S. E., & Bale, A. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0061 · Cited by 87
Functional studies of the MEN1 gene
Chandrasekharappa, S. C., & Teh, B. T. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01165.x · Cited by 71
Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma
Hao, W., Skarulis, M. C., Simonds, W. F., Weinstein, L. S., Agarwal, S. K., Mateo, C., James‐Newton, L., Hobbs, G. R., Gibril, F., Jensen, R. T., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031511 · Cited by 69
Lack of MEN1 gene mutations in 27 sporadic insulinomas
Cupisti, Höppner, Dotzenrath, et al. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00620.x · Cited by 67
Yaguchi, H., Ohkura, N., Tsukada, T., & Yamaguchi, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204132200 · Cited by 65
Identification of MEN1 gene mutations in families with MEN 1 and related disorders
Bergman, L., Teh, B. T., Cardinal, J. W., Palmer, J. M., Walters, M. K., Shepherd, J. J., Cameron, D. P., & Hayward, N. K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1380 · Cited by 62
Studies of the Murine Homolog of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene, men1
Bassett, J. H. D., Rashbass, P., Harding, B., Forbes, S. A., Pannett, A. A. J., & Thakker, R. V. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.3 · Cited by 60
Self-citationCebrián, A., Ruiz-Llorente, S., Cascón, A., Pollán, M., Díez, J. J., Picó, A., Tellería, D., Benítez, J., & Robledo, M. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.e72 · Cited by 60
Stalberg, P. L. H., Grimfjärd, P., Santesson, M., Zhou, Y., Lindberg, D. M., Gobl, A., Öberg, K., Westin, G., Rastad, J., Wang, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031228 · Cited by 59
Nord, B., Platz, A., Smoczynski, K., Kytölä, S. I., Robertson, G. P., Calender, A., Murat, A., Weintraub, D., Burgess, J. R., Edwards, M. J., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<463::aid-ijc1>3.0.co;2-8 · Cited by 55
Wyser, C. P., & Bolliger, C. T. (1997) · KARGER eBooks · doi:10.1159/000062069 · Cited by 49
Hussein, N., Casse, H., Fontanière, S., Morera, A.-M., Asensio, M., Bakeli, S., Lu, J. L., Coste, I., di Clemente, N., Bertolino, P., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.038 · Cited by 44
Somatic Mutations of the MEN1 Tumor Suppressor Gene Detected in Sporadic Angiofibromas
Böni, R., Vortmeyer, A. O., Pack, S., Park, W.-S., Burg, G., Darling, T. N., Liotta, L. A., & Zhuang, Z. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00317.x · Cited by 43
Characteristics of the Danish families with multiple endocrine neoplasia type 1
Jäger, A. C., Friis-Hansen, L. J., Hansen, T. V. O., Eskildsen, P. C., Sølling, K., Knigge, U., Hansen, C. P., Andersen, P. H., Brixen, K., Feldt‐Rasmussen, U., et al. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.02.008 · Cited by 28
Yumita, W., IKEO, Y., Yamauchi, K., Sakurai, A., & Hashizume, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10885 · Cited by 25
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Self-citationGastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 488
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Agarwal, S. K., Mateo, C. M., & Marx, S. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2083 · Cited by 318
Metadata
- Authors
- Lemos, M. C., & Thakker, R. V.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 29
- Issue
- 1
- Pages
- 22-32
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2171395146
- Cited by
- 675
- References
- 88
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.